Connacht Asset Management’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$279K Buy
13,680
+634
+5% +$15.9K 1.65% 34
2023
Q2
$381K Sell
13,046
-19,051
-59% -$522K 0.52% 56
2023
Q1
$902K Buy
32,097
+4,984
+18% +$128K 0.38% 31
2022
Q4
$502K Sell
27,113
-7,938
-23% -$136K 0.23% 66
2022
Q3
$552K Sell
35,051
-55,226
-61% -$1.24M 0.39% 66
2022
Q2
$2.28M Buy
90,277
+40,116
+80% +$1.2M 0.96% 14
2022
Q1
$1.81M Buy
50,161
+29,805
+146% +$1.47M 0.93% 23
2021
Q4
$1.56M Buy
+20,356
New +$1.8M 1.52% 25

Other funds holding CRNC

Connacht Asset Management's CRNC Position: Q3 2023 in Review

Connacht Asset Management increased its Cerence (CRNC) stake by 4.9% in Q3 2023, buying an estimated $15.9K and bringing the position to 13,680 shares worth $279K. The position accounts for 1.65% of the portfolio, ranked #34.

Connacht Asset Management first reported a position in CRNC in Q4 2021 and has held it in 8 quarters since. The position peaked at $2.28M in Q2 2022. 216 funds tracked by Wall St. Rank hold CRNC as of Q3 2023.

  • Connacht Asset Management held 13,680 shares of Cerence worth $279K as of Q3 2023.
  • Connacht Asset Management bought 634 Cerence shares in Q3 2023, an estimated $15.9K.
  • Cerence made up 1.65% of Connacht Asset Management's portfolio in Q3 2023, its #34 holding.
  • Connacht Asset Management first reported a position in Cerence in Q4 2021 and has held it in 8 quarters since.
  • Connacht Asset Management's Cerence position peaked at $2.28M in Q2 2022.
  • 216 funds tracked by Wall St. Rank held Cerence as of Q3 2023.

Based on Connacht Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.